Charles River Laboratories International, Inc. (CRL)
NYSE ยท Healthcare ยท Medical - Diagnostics & Research
Market Cap$7.27B
Sector
Healthcare
IndustryMedical - Diagnostics & Research
52-Week Low$132.58
52-Week High$228.88
CEOJames C. Foster
IPO DateJun 23, 2000
Employees18,700
CountryUnited States
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers.